INSP Intrinsic Value – Deadline Alert: Bernstein Liebhard LLP Reminds Investors of Upcoming Deadline in Lawsuit Against Inspire Medical Systems,
January 5, 2024
☀️Trending News
INSPIRE MEDICAL SYSTEMS ($NYSE:INSP) Inc. (NYSE: INSP) is a medical technology company that develops implantable systems to treat obstructive sleep apnea (OSA). It is currently the only FDA-approved neurostimulation technology for the treatment of OSA. According to Bernstein Liebhard LLP, the lawsuit alleges that Inspire Medical Systems may have misrepresented or omitted key facts in its SEC filings and press releases regarding its business and operations. Bernstein Liebhard LLP is offering free legal evaluations to investors who purchased Inspire Medical Systems securities during this period.
All information will be kept strictly confidential. For more information, visit http://www.bernlieb.com.
Price History
On Tuesday, Inspire Medical Systems stock opened at $184.6 and closed at $187.8, a drop of 7.7% from its last closing price of $203.4. If you wish to discuss your legal rights regarding the pending lawsuit, please contact Bernstein Liebhard LLP as soon as possible to discuss your rights or interests with respect to this class action. Those with information, knowledge or experience relevant to this investigation are encouraged to contact Bernstein Liebhard LLP for a confidential consultation about the case. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for INSP. More…
| Total Revenues | Net Income | Net Margin |
| 570.19 | -32.77 | -5.7% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for INSP. More…
| Operations | Investing | Financing |
| 26.66 | -146.05 | 31.35 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for INSP. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 639.49 | 95.31 | 18.43 |
Key Ratios Snapshot
Some of the financial key ratios for INSP are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 80.9% | – | -5.6% |
| FCF Margin | ROE | ROA |
| 1.4% | -3.7% | -3.1% |
Analysis – INSP Intrinsic Value
GoodWhale recently conducted an analysis of INSPIRE MEDICAL SYSTEMS’ wellbeing. After assessing multiple factors, our proprietary Valuation Line estimated the fair value of each share of INSPIRE MEDICAL SYSTEMS to be around $411.3. However, the company’s stock is currently trading at just $187.8 – a 54.3% undervaluation of its true worth. This represents an opportunity for investors to acquire shares at a discounted price. More…
Peers
The company’s competitors include ShockWave Medical Inc, InMode Ltd, and INVO Bioscience Inc.
– ShockWave Medical Inc ($NASDAQ:SWAV)
ShockWave Medical Inc is a medical device company that uses shockwave technology to treat cardiovascular disease. The company has a market cap of 9.73B as of 2022 and a return on equity of 19.56%. The company’s products are used to treat a variety of cardiovascular diseases, including coronary artery disease, peripheral artery disease, and heart failure.
– InMode Ltd ($NASDAQ:INMD)
InMode Ltd is a medical technology company that develops and manufactures minimally invasive aesthetic solutions. The company has a market capitalization of $2.71 billion as of 2022 and a return on equity of 41.58%. InMode’s products are used by physicians and patients in over 90 countries and the company has a strong presence in the United States, Europe, Asia, and Latin America. InMode’s products are backed by clinical research and have been featured in numerous peer-reviewed journals.
– INVO Bioscience Inc ($NASDAQ:INVO)
INVO Bioscience Inc is a medical device company that has developed a patented in vivo intravaginal culture (IVC) system, which is used to treat infertility. The company’s IVC system is designed to provide a more natural environment for embryo development and is intended to improve the success rates of in vitro fertilization (IVF). INVO Bioscience’s IVC system is currently being used at fertility clinics in the United States and Europe.
Summary
Investors in INSPIRE MEDICAL SYSTEMS, INC. should be aware that the stock price has recently moved down following an alert from Bernstein Liebhard LLP. Analysts suggest that investors should closely monitor the company’s performance and financials in order to gain insight into future price movements. INSPIRE MEDICAL SYSTEMS, INC. is a publicly traded company that specializes in medical devices and treatments, and investors should consider both the value of the company and its risk-reward profile when making an investment decision.
Factors to watch include new product launches, financial results, and industry trends. Investors should also be aware of any news or developments related to the company’s operations and management.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
